Research is exploring the metabolic aspects of atherosclerosis, focusing on macrophage reprogramming and potential therapeutic targets. Studies are investigating various factors, including mitochondrial metabolism, epigenetics, and immune-inflammatory-metabolic interactions, to better understand the disease. The findings may lead to novel approaches for atherosclerosis therapy, although the specific applications and outcomes of these studies are not yet clear.